Literature DB >> 2337878

Nasopharyngeal carcinoma in young patients.

J S Sham1, Y F Poon, W I Wei, D Choy.   

Abstract

Seventy-one Chinese patients ranging in age from 9 to 20 years who had histologically verified nasopharyngeal carcinoma were reviewed. The presenting symptoms were often multiple, comprising nasal (77.5%) and ear (73.2%) symptoms, headache (60.6%), and neck swelling (63.4%). The median duration of these symptoms was 2 to 3 months, and 90.1% of the patients were Stage III or IV at presentation. All patients were treated primarily by radiotherapy. Forty-four of the 71 patients died of the disease; the median time to death was 18 months. Nasopharyngeal carcinoma in the young patients in Hong Kong does not appear to be different from that of the adult population in Hong Kong in terms of histology, pattern of relapse, and survival. Compared with the adult patients, however, the current series of young patients presented with more advanced-staged disease. The incidence of nasopharyngeal carcinoma in Hong Kong was compared with Chinese populations in other parts of the world, and the general pattern was comparable. The only postadolescent peak was found in the Chinese population of San Francisco.

Entities:  

Mesh:

Year:  1990        PMID: 2337878     DOI: 10.1002/1097-0142(19900601)65:11<2606::aid-cncr2820651135>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Prognostic factors and long-term outcomes of childhood nasopharyngeal carcinoma.

Authors:  Daniel Ka Leung Cheuk; Catherine A Billups; Michael G Martin; Cynthia R Roland; Raul C Ribeiro; Matthew J Krasin; Carlos Rodriguez-Galindo
Journal:  Cancer       Date:  2010-08-24       Impact factor: 6.860

2.  Comparison of Prognosis Between Juvenile and Adult Nasopharyngeal Carcinoma: A Propensity Score-Matched Analysis.

Authors:  Chuanben Chen; Qinyan Chen; Yuanji Xu; Wei Zheng; Zhizhong Lin; Zijie Wu; Wangzhong Ye; Xinyi Huang; Xiurong Lin; Penggang Bai
Journal:  Cancer Manag Res       Date:  2020-09-18       Impact factor: 3.989

3.  Current management strategy of nasopharyngeal carcinoma.

Authors:  William I Wei; Dora L W Kwong
Journal:  Clin Exp Otorhinolaryngol       Date:  2010-03-30       Impact factor: 3.372

4.  Nasopharyngeal carcinoma: the role of the Epstein-Barr virus.

Authors:  Eugene A Chu; Julie M Wu; David E Tunkel; Stacey L Ishman
Journal:  Medscape J Med       Date:  2008-07-16

5.  Nasopharyngeal carcinoma in adolescents: a retrospective review of 42 patients.

Authors:  Said Afqir; Nabil Ismaili; Khaoula Alaoui; Samir Ahid; Jean-Pierre Lotz; Elizabeth Horn; Touria Bouhafa; Redouane Abouqal; Hassan Errihani
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-01-22       Impact factor: 2.503

Review 6.  Prognostic aspects in the treatment of juvenile nasopharyngeal carcinoma: a systematic review.

Authors:  Federico Maria Gioacchini; Michele Tulli; Shaniko Kaleci; Giuseppe Magliulo; Massimo Re
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-18       Impact factor: 2.503

7.  Cancer Screening in Refugees and Immigrants: A Global Perspective.

Authors:  Patricia F Walker; Ann Settgast; Malini B DeSilva
Journal:  Am J Trop Med Hyg       Date:  2022-05-09       Impact factor: 3.707

8.  Epstein- Barr Virus: Clinical and Epidemiological Revisits and Genetic Basis of Oncogenesis.

Authors:  Abdelwahid Saeed Ali; Mubarak Al-Shraim; Ahmed Musa Al-Hakami; Ian M Jones
Journal:  Open Virol J       Date:  2015-11-03

9.  Plasma Epstein-Barr Viral Deoxyribonucleic Acid Predicts Worse Outcomes in Pediatric Nonmetastatic Nasopharyngeal Carcinoma Patients: An Observational Study of 89 Cases in an Endemic Area.

Authors:  Ting Shen; Lin-Quan Tang; Wei-Guang Gu; Dong-Hua Luo; Qiu-Yan Chen; Pei-Jing Li; Dong-Mei Mai; Hai-Qiang Mai; Hao-Yuan Mo
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

10.  Head and neck carcinomas in patients under the age of forty years.

Authors:  M Tsukuda; K Ooishi; I Mochimatsu; H Sato
Journal:  Jpn J Cancer Res       Date:  1993-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.